Scientific Advisory Board (SAB)

Overview

The Scientific Advisory Board (SAB) guides our Board and executive team in setting research priorities and evaluating potential projects. Our SAB consists of a strong multi-disciplinary team which brings together a mix of research and commercial experience covering drug discovery, epigenetics, genetics, neurodevelopmental disorders, preclinical and clinical trials, venture capital and biotech management.

Scientific Advisory Board

Ronald Cohn, MD, FACMG

Ronald Cohn joined The Hospital for Sick Children as the Chief of the Division of Clinical and Metabolic Genetics, Co-Director of the Centre for […]

Sunny Kumar, MHSc, PhD

Dr. Sunny Kumar is an experienced professional recognized for engaging directly with healthcare companies and mentoring them in the […]

Neil Kumar, PhD

Dr. Neil Kumar, PhD, is the CEO of BridgeBio LLC, a company focused on the development of novel therapies for rare genetic disorders. […]

Jamie M. Kramer, BSc, PhD

Dr. Kramer is an Assistant Professor at the University of Western Ontario. He leads a research team investigating the functional role […]

Brian Van Ness, PhD

Brian Van Ness, PhD, is a professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota Medical […]